Vis enkel innførsel

dc.contributor.authorAarsetøy, Reidun
dc.contributor.authorOmland, Torbjørn
dc.contributor.authorRøsjø, Helge
dc.contributor.authorStrand, Heidi
dc.contributor.authorLindner, Thomas Werner
dc.contributor.authorAarsetøy, Hildegunn
dc.contributor.authorStaines, Harry
dc.contributor.authorNilsen, Dennis W.T.
dc.date.accessioned2021-03-12T09:45:10Z
dc.date.available2021-03-12T09:45:10Z
dc.date.created2020-09-30T11:59:09Z
dc.date.issued2020-08-24
dc.PublishedBMC Cardiovascular Disorders. 2020, 20:382 1-10.
dc.identifier.issn1471-2261
dc.identifier.urihttps://hdl.handle.net/11250/2733077
dc.description.abstractBackground Early risk stratification applying cardiac biomarkers may prove useful in sudden cardiac arrest patients. We investigated the prognostic utility of early-on levels of high sensitivity cardiac troponin-T (hs-cTnT), copeptin and N-terminal pro-B-type natriuretic peptide (NT-proBNP) in patients with out-of-hospital cardiac arrest (OHCA). Methods We conducted a prospective observational unicenter study, including patients with OHCA of assumed cardiac origin from the southwestern part of Norway from 2007 until 2010. Blood samples for later measurements were drawn during cardiopulmonary resuscitation or at hospital admission. Results A total of 114 patients were included, 37 patients with asystole and 77 patients with VF as first recorded heart rhythm. Forty-four patients (38.6%) survived 30-day follow-up. Neither hs-cTnT (p = 0.49), nor copeptin (p = 0.39) differed between non-survivors and survivors, whereas NT-proBNP was higher in non-survivors (p <  0.001) and significantly associated with 30-days all-cause mortality in univariate analysis, with a hazard ratio (HR) for patients in the highest compared to the lowest quartile of 4.6 (95% confidence interval (CI), 2.1–10.1), p <  0.001. This association was no longer significant in multivariable analysis applying continuous values, [HR 0.96, (95% CI, 0.64–1.43), p = 0.84]. Similar results were obtained by dividing the population by survival at hospital admission, excluding non-return of spontaneous circulation (ROSC) patients on scene [HR 0.93 (95% CI, 0.50–1.73), P = 0.83]. We also noted that NT-proBNP was significantly higher in asystole- as compared to VF-patients, p <  0.001. Conclusions Early-on levels of hs-cTnT, copeptin and NT-proBNP did not provide independent prognostic information following OHCA. Prediction was unaffected by excluding on-scene non-ROSC patients in the multivariable analysis.en_US
dc.language.isoengen_US
dc.publisherBMCen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleN-terminal pro-B-type natriuretic peptide as a prognostic indicator for 30-day mortality following out-of-hospital cardiac arrest: A prospective observational studyen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright the authorsen_US
dc.source.articlenumber382 (2020)en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doi10.1186/s12872-020-01630-x
dc.identifier.cristin1835502
dc.source.journalBMC Cardiovascular Disordersen_US
dc.source.4020:382
dc.source.pagenumber1-10en_US
dc.identifier.citationBMC Cardiovascular Disorders. 2020, 20, 382 (2020)en_US
dc.source.volume20en_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal